Correction to: Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma ; volume:20 ; number:1 ; day:2 ; month:10 ; year:2020 ; pages:1 ; date:12.2020
Cancer cell international ; 20, Heft 1 (2.10.2020), 1, 12.2020
- Urheber
-
Lv, Lei
Zhao, Yujia
Wei, Qinqin
Zhao, Ye
Yi, Qiyi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-020-01575-3
- URN
-
urn:nbn:de:101:1-2020112117563447039220
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lv, Lei
- Zhao, Yujia
- Wei, Qinqin
- Zhao, Ye
- Yi, Qiyi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
Toward a better understanding of hepatocellular carcinoma immune infiltrates
CD1C is associated with breast cancer prognosis and immune infiltrates
High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma
Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
SESN2 correlates with advantageous prognosis in hepatocellular carcinoma
Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis
CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma
TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma
PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma
DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates
Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
Toward a better understanding of hepatocellular carcinoma immune infiltrates
CD1C is associated with breast cancer prognosis and immune infiltrates
High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma
Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
SESN2 correlates with advantageous prognosis in hepatocellular carcinoma
Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis
CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma
TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma
PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma
DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates
Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
Toward a better understanding of hepatocellular carcinoma immune infiltrates
CD1C is associated with breast cancer prognosis and immune infiltrates
High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma
Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
SESN2 correlates with advantageous prognosis in hepatocellular carcinoma
Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis
CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma
TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma
PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma
DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma